CINECA IRIS Institutional Research Information System

TORREGROSSA, LIBORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.442
AS - Asia 4.965
EU - Europa 4.167
SA - Sud America 789
AF - Africa 383
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 19.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.205
SG - Singapore 1.676
IT - Italia 1.393
CN - Cina 1.292
HK - Hong Kong 770
BR - Brasile 655
DE - Germania 651
SE - Svezia 568
VN - Vietnam 453
AT - Austria 298
GB - Regno Unito 283
BG - Bulgaria 208
FR - Francia 199
CI - Costa d'Avorio 168
FI - Finlandia 163
IN - India 144
TR - Turchia 140
CA - Canada 136
RU - Federazione Russa 124
JP - Giappone 123
SN - Senegal 78
BD - Bangladesh 57
KR - Corea 56
NL - Olanda 51
AR - Argentina 45
PL - Polonia 45
IQ - Iraq 43
MX - Messico 42
ZA - Sudafrica 37
MA - Marocco 36
PK - Pakistan 33
UA - Ucraina 30
ES - Italia 27
SA - Arabia Saudita 27
ID - Indonesia 26
NG - Nigeria 25
EC - Ecuador 23
UZ - Uzbekistan 18
VE - Venezuela 17
CZ - Repubblica Ceca 16
CH - Svizzera 15
BE - Belgio 14
EE - Estonia 14
CO - Colombia 13
IR - Iran 13
LT - Lituania 13
IE - Irlanda 12
JO - Giordania 12
KE - Kenya 11
NP - Nepal 11
PH - Filippine 11
GR - Grecia 9
PE - Perù 9
PY - Paraguay 9
CL - Cile 8
HU - Ungheria 8
JM - Giamaica 8
PA - Panama 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
TT - Trinidad e Tobago 7
AU - Australia 6
AZ - Azerbaigian 6
EG - Egitto 6
EU - Europa 6
HN - Honduras 6
MY - Malesia 6
PS - Palestinian Territory 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
KZ - Kazakistan 5
OM - Oman 5
CR - Costa Rica 4
GT - Guatemala 4
IL - Israele 4
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
GD - Grenada 3
LK - Sri Lanka 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BB - Barbados 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MT - Malta 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
BH - Bahrain 1
BM - Bermuda 1
Totale 19.739
Salva come PNG Salva come JPEG
Città #
Dallas 1.157
Ashburn 1.154
Singapore 951
San Jose 764
Hong Kong 756
Chandler 660
Fairfield 574
Santa Clara 547
Woodbridge 386
Milan 308
Shanghai 288
Houston 285
Seattle 277
Vienna 265
New York 262
Beijing 246
Ann Arbor 219
Sofia 206
Wilmington 205
Los Angeles 204
Cambridge 202
Abidjan 168
Boardman 159
Munich 147
Pisa 143
Ho Chi Minh City 136
Florence 122
Princeton 119
Serra 119
Tokyo 111
Lawrence 99
Lauterbourg 95
Frankfurt am Main 85
London 85
Medford 83
Hanoi 81
Dakar 78
Hefei 72
Council Bluffs 65
Rome 65
Turku 65
Ottawa 61
Istanbul 59
São Paulo 59
Helsinki 54
Buffalo 53
San Diego 52
Seoul 47
Redondo Beach 46
Bremen 40
Cascina 39
Nanjing 33
Dong Ket 32
Izmir 32
Des Moines 31
Orem 31
Ogden 29
Warsaw 29
Vicopisano 28
Poplar 26
Belo Horizonte 25
Chicago 24
Columbus 24
Redmond 24
Montreal 23
Paris 23
Atlanta 22
Lagos 22
Rio de Janeiro 22
Brooklyn 21
Düsseldorf 21
Johannesburg 21
Phoenix 21
Boulder 20
Nuremberg 20
Amsterdam 19
Fuzhou 19
Haiphong 19
Brasília 18
Lancaster 18
Lucca 18
Manchester 18
Naples 18
Toronto 18
Guangzhou 17
Hyderabad 17
Tashkent 17
Ankara 16
Casablanca 16
Chennai 16
Denver 16
Quanzhou 16
Baghdad 15
Dearborn 15
Zhengzhou 15
Norwalk 14
Bologna 13
Da Nang 13
Mumbai 13
Stockholm 13
Totale 13.534
Salva come PNG Salva come JPEG
Nome #
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 275
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 253
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 239
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 235
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 234
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 233
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 224
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 220
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 218
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 214
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 212
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 207
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 204
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 203
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 200
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 198
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 190
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 189
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 188
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 188
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 186
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 183
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 181
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 179
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 179
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 178
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 177
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 177
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 177
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 176
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 176
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 173
Impact of energy-based devices in pediatric thyroid surgery 173
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 172
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I 171
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 171
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 170
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 170
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 167
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 166
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 166
Role of oxidative stress in radio-induced DNA damage and in RET/PTC rearrangement in papillary thyroid cancer 164
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 164
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features 163
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 163
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 163
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 162
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 162
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 162
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 162
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 161
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism 161
null 160
null 159
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 159
A large functioning parathyroid lipoadenoma 156
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 155
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 155
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 155
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 155
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 155
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 155
An adrenal cortical adenoma with neuroendocrine-type granules mimicking pheochromocytoma 154
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 154
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. 153
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 153
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 151
Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements 150
COVID-19 autopsy cases: detection of virus in endocrine tissues 150
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I 149
Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity 149
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 147
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 146
Do Patients with Atypical Parathyroid Adenoma Need Close Follow-up? 146
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 145
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 142
Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies 142
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 141
Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis 139
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 138
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. 137
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma 137
CXC Chemokine Receptor 4 Immunodetection in the Follicular Variant of Papillary Thyroid Carcinoma: Comparison to Galectin-3 and Hector Battifora Mesothelial Cell-1 134
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 133
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance 132
High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience 131
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 130
Galectin-3 is highly expressed in nonencapsutated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothetial cell 1 immunoreactivity 129
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 129
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 126
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 125
Correlation of the presurgical diagnosis of follicular variant of papillary thyroid cancer with the disease status after 10 years of follow-up. 125
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 124
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions 124
A Case of Unilateral Dermopathy Possibly Related to Graves' Disease 123
First report of benign track seeding after robot-assisted transaxillary thyroid surgery 123
Atypical parathyroid adenomas: Challenging lesions in the differential diagnosis of endocrine tumors 123
Molecular genetics of follicular-derived thyroid cancer 120
Totale 16.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.206 27 24 41 48 198 223 58 42 74 63 104 304
2022/20232.376 227 351 197 200 250 260 29 192 473 11 152 34
2023/20241.487 117 132 192 169 177 264 76 37 29 39 108 147
2024/20254.614 46 146 63 263 453 452 376 206 461 530 502 1.116
2025/20266.835 443 897 949 702 701 437 957 302 339 672 222 214
2026/202716 16 0 0 0 0 0 0 0 0 0 0 0
Totale 20.134